TCE-RRMM
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab (NCT07320326) | Peking University People's Hospital | 2025-12-30 |
Track TCE-RRMM automatically
Every clearance here is in the API, with alerts when new ones post.